nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—prostate cancer—testicular cancer	0.365	1	CtDrD
Estramustine—Alkylating Activity—Ifosfamide—testicular cancer	0.289	0.529	CiPCiCtD
Estramustine—Alkylating Activity—Chlorambucil—testicular cancer	0.257	0.471	CiPCiCtD
Estramustine—ABCB1—Dactinomycin—testicular cancer	0.00732	0.193	CbGbCtD
Estramustine—ESR2—seminiferous tubule of testis—testicular cancer	0.00638	0.288	CbGeAlD
Estramustine—CYP3A4—Ifosfamide—testicular cancer	0.00518	0.137	CbGbCtD
Estramustine—ABCB1—Vinblastine—testicular cancer	0.00458	0.121	CbGbCtD
Estramustine—ABCB1—Cisplatin—testicular cancer	0.0042	0.111	CbGbCtD
Estramustine—ABCB1—Etoposide—testicular cancer	0.00413	0.109	CbGbCtD
Estramustine—ABCB1—Doxorubicin—testicular cancer	0.00282	0.0744	CbGbCtD
Estramustine—CYP3A4—Vinblastine—testicular cancer	0.00275	0.0725	CbGbCtD
Estramustine—ABCB1—Methotrexate—testicular cancer	0.00273	0.072	CbGbCtD
Estramustine—CYP3A4—Etoposide—testicular cancer	0.00247	0.0653	CbGbCtD
Estramustine—MAP1A—embryo—testicular cancer	0.00216	0.0976	CbGeAlD
Estramustine—CYP3A4—Doxorubicin—testicular cancer	0.00169	0.0446	CbGbCtD
Estramustine—MAP1A—gonad—testicular cancer	0.00147	0.0663	CbGeAlD
Estramustine—MAP2—embryo—testicular cancer	0.00123	0.0555	CbGeAlD
Estramustine—MAP1A—female gonad—testicular cancer	0.00119	0.0538	CbGeAlD
Estramustine—MAP2—seminal vesicle—testicular cancer	0.00115	0.0521	CbGeAlD
Estramustine—MAP1A—testis—testicular cancer	0.00106	0.0478	CbGeAlD
Estramustine—MAP2—gonad—testicular cancer	0.000834	0.0376	CbGeAlD
Estramustine—MAP1A—lymph node—testicular cancer	0.000767	0.0346	CbGeAlD
Estramustine—MAP2—female gonad—testicular cancer	0.000678	0.0306	CbGeAlD
Estramustine—MAP2—testis—testicular cancer	0.000601	0.0271	CbGeAlD
Estramustine—ESR1—embryo—testicular cancer	0.000546	0.0246	CbGeAlD
Estramustine—ESR2—gonad—testicular cancer	0.000541	0.0244	CbGeAlD
Estramustine—ESR2—female gonad—testicular cancer	0.000439	0.0198	CbGeAlD
Estramustine—MAP2—lymph node—testicular cancer	0.000436	0.0197	CbGeAlD
Estramustine—ESR2—testis—testicular cancer	0.00039	0.0176	CbGeAlD
Estramustine—ESR1—gonad—testicular cancer	0.00037	0.0167	CbGeAlD
Estramustine—Tenderness—Bleomycin—testicular cancer	0.000341	0.0119	CcSEcCtD
Estramustine—Thromboembolism—Doxorubicin—testicular cancer	0.000328	0.0114	CcSEcCtD
Estramustine—ESR1—female gonad—testicular cancer	0.000301	0.0136	CbGeAlD
Estramustine—Tenderness—Ifosfamide—testicular cancer	0.000291	0.0102	CcSEcCtD
Estramustine—Skin exfoliation—Bleomycin—testicular cancer	0.000284	0.00992	CcSEcCtD
Estramustine—ESR2—lymph node—testicular cancer	0.000282	0.0127	CbGeAlD
Estramustine—ESR1—testis—testicular cancer	0.000267	0.012	CbGeAlD
Estramustine—Cerebrovascular accident—Vinblastine—testicular cancer	0.000261	0.00912	CcSEcCtD
Estramustine—Raised liver function tests—Methotrexate—testicular cancer	0.000261	0.0091	CcSEcCtD
Estramustine—Tenderness—Cisplatin—testicular cancer	0.000251	0.00878	CcSEcCtD
Estramustine—Skin exfoliation—Ifosfamide—testicular cancer	0.000243	0.00848	CcSEcCtD
Estramustine—Myelosuppression—Epirubicin—testicular cancer	0.00024	0.00839	CcSEcCtD
Estramustine—Pancytopenia—Chlorambucil—testicular cancer	0.000229	0.008	CcSEcCtD
Estramustine—Embolism venous—Epirubicin—testicular cancer	0.000223	0.00779	CcSEcCtD
Estramustine—Myelosuppression—Doxorubicin—testicular cancer	0.000222	0.00776	CcSEcCtD
Estramustine—Cerebrovascular accident—Bleomycin—testicular cancer	0.00022	0.0077	CcSEcCtD
Estramustine—ABCB1—embryo—testicular cancer	0.000215	0.00972	CbGeAlD
Estramustine—Hypernatraemia—Epirubicin—testicular cancer	0.000214	0.00748	CcSEcCtD
Estramustine—Thrombophlebitis—Ifosfamide—testicular cancer	0.000213	0.00745	CcSEcCtD
Estramustine—Pancytopenia—Vinblastine—testicular cancer	0.00021	0.00733	CcSEcCtD
Estramustine—Skin exfoliation—Cisplatin—testicular cancer	0.000209	0.00731	CcSEcCtD
Estramustine—Embolism venous—Doxorubicin—testicular cancer	0.000206	0.00721	CcSEcCtD
Estramustine—Lethargy—Dactinomycin—testicular cancer	0.000206	0.00718	CcSEcCtD
Estramustine—ABCB1—seminal vesicle—testicular cancer	0.000202	0.00913	CbGeAlD
Estramustine—Hypernatraemia—Doxorubicin—testicular cancer	0.000198	0.00692	CcSEcCtD
Estramustine—Depression—Vinblastine—testicular cancer	0.000197	0.00686	CcSEcCtD
Estramustine—Acute coronary syndrome—Vinblastine—testicular cancer	0.000194	0.00679	CcSEcCtD
Estramustine—ESR1—lymph node—testicular cancer	0.000193	0.00873	CbGeAlD
Estramustine—Myocardial infarction—Vinblastine—testicular cancer	0.000193	0.00675	CcSEcCtD
Estramustine—Skin exfoliation—Etoposide—testicular cancer	0.000192	0.0067	CcSEcCtD
Estramustine—Lacrimation—Epirubicin—testicular cancer	0.000191	0.00669	CcSEcCtD
Estramustine—Embolism—Methotrexate—testicular cancer	0.000187	0.00655	CcSEcCtD
Estramustine—Liver function test abnormal—Dactinomycin—testicular cancer	0.000186	0.0065	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.000185	0.00645	CcSEcCtD
Estramustine—Pancytopenia—Bleomycin—testicular cancer	0.000177	0.00619	CcSEcCtD
Estramustine—Lacrimation—Doxorubicin—testicular cancer	0.000177	0.00619	CcSEcCtD
Estramustine—Cardiac arrest—Ifosfamide—testicular cancer	0.000176	0.00613	CcSEcCtD
Estramustine—Cardiac failure congestive—Cisplatin—testicular cancer	0.000175	0.00613	CcSEcCtD
Estramustine—Embolism—Epirubicin—testicular cancer	0.000175	0.00613	CcSEcCtD
Estramustine—Alopecia—Chlorambucil—testicular cancer	0.000171	0.00596	CcSEcCtD
Estramustine—Pancytopenia—Dactinomycin—testicular cancer	0.000165	0.00578	CcSEcCtD
Estramustine—Acute coronary syndrome—Bleomycin—testicular cancer	0.000164	0.00573	CcSEcCtD
Estramustine—Myocardial infarction—Bleomycin—testicular cancer	0.000163	0.0057	CcSEcCtD
Estramustine—Cerebrovascular accident—Cisplatin—testicular cancer	0.000162	0.00567	CcSEcCtD
Estramustine—Embolism—Doxorubicin—testicular cancer	0.000162	0.00567	CcSEcCtD
Estramustine—Hypercalcaemia—Epirubicin—testicular cancer	0.000162	0.00566	CcSEcCtD
Estramustine—Cardiac failure congestive—Etoposide—testicular cancer	0.000161	0.00562	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.000159	0.00556	CcSEcCtD
Estramustine—Alopecia—Vinblastine—testicular cancer	0.000156	0.00546	CcSEcCtD
Estramustine—Pancytopenia—Ifosfamide—testicular cancer	0.000152	0.00529	CcSEcCtD
Estramustine—Leukopenia—Chlorambucil—testicular cancer	0.00015	0.00525	CcSEcCtD
Estramustine—Hypercalcaemia—Doxorubicin—testicular cancer	0.00015	0.00524	CcSEcCtD
Estramustine—ABCB1—gonad—testicular cancer	0.000146	0.0066	CbGeAlD
Estramustine—Acute coronary syndrome—Ifosfamide—testicular cancer	0.00014	0.0049	CcSEcCtD
Estramustine—Myocardial infarction—Ifosfamide—testicular cancer	0.000139	0.00487	CcSEcCtD
Estramustine—Flushing—Bleomycin—testicular cancer	0.000139	0.00484	CcSEcCtD
Estramustine—Cardiac arrest—Etoposide—testicular cancer	0.000139	0.00484	CcSEcCtD
Estramustine—Leukopenia—Vinblastine—testicular cancer	0.000138	0.00482	CcSEcCtD
Estramustine—Dysphonia—Epirubicin—testicular cancer	0.000137	0.00478	CcSEcCtD
Estramustine—ESR2—Ovarian Infertility Genes—DAZL—testicular cancer	0.000136	0.533	CbGpPWpGaD
Estramustine—Thrombocytopenia—Chlorambucil—testicular cancer	0.000134	0.00469	CcSEcCtD
Estramustine—Alopecia—Bleomycin—testicular cancer	0.000132	0.00461	CcSEcCtD
Estramustine—Abdominal discomfort—Cisplatin—testicular cancer	0.000132	0.00461	CcSEcCtD
Estramustine—Anorexia—Chlorambucil—testicular cancer	0.000131	0.00457	CcSEcCtD
Estramustine—Pancytopenia—Cisplatin—testicular cancer	0.000131	0.00456	CcSEcCtD
Estramustine—Flushing—Dactinomycin—testicular cancer	0.000129	0.00452	CcSEcCtD
Estramustine—Dysphonia—Doxorubicin—testicular cancer	0.000127	0.00442	CcSEcCtD
Estramustine—Alopecia—Dactinomycin—testicular cancer	0.000123	0.0043	CcSEcCtD
Estramustine—Thrombocytopenia—Vinblastine—testicular cancer	0.000123	0.0043	CcSEcCtD
Estramustine—Lacrimation increased—Epirubicin—testicular cancer	0.000122	0.00427	CcSEcCtD
Estramustine—Acute coronary syndrome—Cisplatin—testicular cancer	0.000121	0.00422	CcSEcCtD
Estramustine—Myocardial infarction—Cisplatin—testicular cancer	0.00012	0.0042	CcSEcCtD
Estramustine—Anorexia—Vinblastine—testicular cancer	0.00012	0.00418	CcSEcCtD
Estramustine—Pancytopenia—Etoposide—testicular cancer	0.00012	0.00418	CcSEcCtD
Estramustine—Decreased appetite—Chlorambucil—testicular cancer	0.000119	0.00416	CcSEcCtD
Estramustine—Tinnitus—Ifosfamide—testicular cancer	0.000119	0.00416	CcSEcCtD
Estramustine—ABCB1—female gonad—testicular cancer	0.000119	0.00536	CbGeAlD
Estramustine—Flushing—Ifosfamide—testicular cancer	0.000119	0.00414	CcSEcCtD
Estramustine—Leukopenia—Bleomycin—testicular cancer	0.000116	0.00407	CcSEcCtD
Estramustine—Skin exfoliation—Methotrexate—testicular cancer	0.000115	0.00401	CcSEcCtD
Estramustine—Lacrimation increased—Doxorubicin—testicular cancer	0.000113	0.00395	CcSEcCtD
Estramustine—Alopecia—Ifosfamide—testicular cancer	0.000113	0.00394	CcSEcCtD
Estramustine—Acute coronary syndrome—Etoposide—testicular cancer	0.000111	0.00387	CcSEcCtD
Estramustine—Chest pain—Bleomycin—testicular cancer	0.000111	0.00387	CcSEcCtD
Estramustine—Myocardial infarction—Etoposide—testicular cancer	0.00011	0.00385	CcSEcCtD
Estramustine—Decreased appetite—Vinblastine—testicular cancer	0.000109	0.00382	CcSEcCtD
Estramustine—Leukopenia—Dactinomycin—testicular cancer	0.000109	0.00379	CcSEcCtD
Estramustine—Gynaecomastia—Methotrexate—testicular cancer	0.000108	0.00376	CcSEcCtD
Estramustine—Skin exfoliation—Epirubicin—testicular cancer	0.000107	0.00375	CcSEcCtD
Estramustine—Oedema—Bleomycin—testicular cancer	0.000106	0.00371	CcSEcCtD
Estramustine—ABCB1—testis—testicular cancer	0.000105	0.00476	CbGeAlD
Estramustine—Thrombocytopenia—Bleomycin—testicular cancer	0.000104	0.00363	CcSEcCtD
Estramustine—Cramps of lower extremities—Epirubicin—testicular cancer	0.000103	0.00361	CcSEcCtD
Estramustine—Tinnitus—Cisplatin—testicular cancer	0.000103	0.00359	CcSEcCtD
Estramustine—Flushing—Cisplatin—testicular cancer	0.000102	0.00357	CcSEcCtD
Estramustine—Anorexia—Bleomycin—testicular cancer	0.000101	0.00353	CcSEcCtD
Estramustine—Thrombophlebitis—Methotrexate—testicular cancer	0.000101	0.00352	CcSEcCtD
Estramustine—Leukopenia—Ifosfamide—testicular cancer	9.95e-05	0.00348	CcSEcCtD
Estramustine—Skin exfoliation—Doxorubicin—testicular cancer	9.95e-05	0.00347	CcSEcCtD
Estramustine—Oedema—Dactinomycin—testicular cancer	9.9e-05	0.00346	CcSEcCtD
Estramustine—Alopecia—Cisplatin—testicular cancer	9.73e-05	0.0034	CcSEcCtD
Estramustine—Pruritus—Chlorambucil—testicular cancer	9.71e-05	0.00339	CcSEcCtD
Estramustine—Thrombocytopenia—Dactinomycin—testicular cancer	9.69e-05	0.00339	CcSEcCtD
Estramustine—Cramps of lower extremities—Doxorubicin—testicular cancer	9.57e-05	0.00334	CcSEcCtD
Estramustine—Dyspnoea—Bleomycin—testicular cancer	9.47e-05	0.00331	CcSEcCtD
Estramustine—Chest pain—Ifosfamide—testicular cancer	9.47e-05	0.00331	CcSEcCtD
Estramustine—Flatulence—Cisplatin—testicular cancer	9.44e-05	0.0033	CcSEcCtD
Estramustine—Thrombophlebitis—Epirubicin—testicular cancer	9.44e-05	0.0033	CcSEcCtD
Estramustine—Anorexia—Dactinomycin—testicular cancer	9.44e-05	0.0033	CcSEcCtD
Estramustine—Diarrhoea—Chlorambucil—testicular cancer	9.39e-05	0.00328	CcSEcCtD
Estramustine—Flushing—Etoposide—testicular cancer	9.36e-05	0.00327	CcSEcCtD
Estramustine—Decreased appetite—Bleomycin—testicular cancer	9.23e-05	0.00322	CcSEcCtD
Estramustine—Muscle spasms—Cisplatin—testicular cancer	9.22e-05	0.00322	CcSEcCtD
Estramustine—Oedema—Ifosfamide—testicular cancer	9.07e-05	0.00317	CcSEcCtD
Estramustine—Eye pain—Epirubicin—testicular cancer	9.05e-05	0.00316	CcSEcCtD
Estramustine—Cardiac failure congestive—Epirubicin—testicular cancer	9.01e-05	0.00315	CcSEcCtD
Estramustine—Alopecia—Etoposide—testicular cancer	8.91e-05	0.00311	CcSEcCtD
Estramustine—Cerebrovascular accident—Methotrexate—testicular cancer	8.91e-05	0.00311	CcSEcCtD
Estramustine—Lethargy—Methotrexate—testicular cancer	8.91e-05	0.00311	CcSEcCtD
Estramustine—Thrombocytopenia—Ifosfamide—testicular cancer	8.88e-05	0.0031	CcSEcCtD
Estramustine—Hot flush—Epirubicin—testicular cancer	8.74e-05	0.00305	CcSEcCtD
Estramustine—Thrombophlebitis—Doxorubicin—testicular cancer	8.74e-05	0.00305	CcSEcCtD
Estramustine—Vomiting—Chlorambucil—testicular cancer	8.72e-05	0.00305	CcSEcCtD
Estramustine—Menopausal symptoms—Epirubicin—testicular cancer	8.66e-05	0.00303	CcSEcCtD
Estramustine—Anorexia—Ifosfamide—testicular cancer	8.65e-05	0.00302	CcSEcCtD
Estramustine—Decreased appetite—Dactinomycin—testicular cancer	8.61e-05	0.00301	CcSEcCtD
Estramustine—Diarrhoea—Vinblastine—testicular cancer	8.6e-05	0.003	CcSEcCtD
Estramustine—Leukopenia—Cisplatin—testicular cancer	8.58e-05	0.003	CcSEcCtD
Estramustine—Muscle spasms—Etoposide—testicular cancer	8.44e-05	0.00295	CcSEcCtD
Estramustine—Eye pain—Doxorubicin—testicular cancer	8.38e-05	0.00293	CcSEcCtD
Estramustine—Lethargy—Epirubicin—testicular cancer	8.34e-05	0.00291	CcSEcCtD
Estramustine—Cerebrovascular accident—Epirubicin—testicular cancer	8.34e-05	0.00291	CcSEcCtD
Estramustine—Cardiac failure congestive—Doxorubicin—testicular cancer	8.34e-05	0.00291	CcSEcCtD
Estramustine—Mood swings—Methotrexate—testicular cancer	8.27e-05	0.00289	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	8.17e-05	0.00285	CcSEcCtD
Estramustine—Nausea—Chlorambucil—testicular cancer	8.15e-05	0.00285	CcSEcCtD
Estramustine—Anxiety—Cisplatin—testicular cancer	8.13e-05	0.00284	CcSEcCtD
Estramustine—Dyspnoea—Ifosfamide—testicular cancer	8.09e-05	0.00283	CcSEcCtD
Estramustine—Hot flush—Doxorubicin—testicular cancer	8.08e-05	0.00282	CcSEcCtD
Estramustine—Liver function test abnormal—Methotrexate—testicular cancer	8.06e-05	0.00282	CcSEcCtD
Estramustine—Affect lability—Epirubicin—testicular cancer	8.04e-05	0.00281	CcSEcCtD
Estramustine—Menopausal symptoms—Doxorubicin—testicular cancer	8.01e-05	0.0028	CcSEcCtD
Estramustine—Vomiting—Vinblastine—testicular cancer	7.99e-05	0.00279	CcSEcCtD
Estramustine—Decreased appetite—Ifosfamide—testicular cancer	7.89e-05	0.00275	CcSEcCtD
Estramustine—Headache—Vinblastine—testicular cancer	7.88e-05	0.00275	CcSEcCtD
Estramustine—Leukopenia—Etoposide—testicular cancer	7.86e-05	0.00275	CcSEcCtD
Estramustine—Oedema—Cisplatin—testicular cancer	7.82e-05	0.00273	CcSEcCtD
Estramustine—Cardiac arrest—Epirubicin—testicular cancer	7.77e-05	0.00271	CcSEcCtD
Estramustine—Mood swings—Epirubicin—testicular cancer	7.74e-05	0.0027	CcSEcCtD
Estramustine—Lethargy—Doxorubicin—testicular cancer	7.72e-05	0.0027	CcSEcCtD
Estramustine—Cerebrovascular accident—Doxorubicin—testicular cancer	7.72e-05	0.0027	CcSEcCtD
Estramustine—Thrombocytopenia—Cisplatin—testicular cancer	7.66e-05	0.00267	CcSEcCtD
Estramustine—ABCB1—lymph node—testicular cancer	7.64e-05	0.00345	CbGeAlD
Estramustine—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	7.56e-05	0.00264	CcSEcCtD
Estramustine—Liver function test abnormal—Epirubicin—testicular cancer	7.55e-05	0.00264	CcSEcCtD
Estramustine—Pruritus—Bleomycin—testicular cancer	7.51e-05	0.00262	CcSEcCtD
Estramustine—Dry skin—Epirubicin—testicular cancer	7.49e-05	0.00262	CcSEcCtD
Estramustine—Chest pain—Etoposide—testicular cancer	7.48e-05	0.00261	CcSEcCtD
Estramustine—Nausea—Vinblastine—testicular cancer	7.47e-05	0.00261	CcSEcCtD
Estramustine—Anorexia—Cisplatin—testicular cancer	7.46e-05	0.0026	CcSEcCtD
Estramustine—Affect lability—Doxorubicin—testicular cancer	7.44e-05	0.0026	CcSEcCtD
Estramustine—Abdominal discomfort—Methotrexate—testicular cancer	7.24e-05	0.00253	CcSEcCtD
Estramustine—Cardiac arrest—Doxorubicin—testicular cancer	7.19e-05	0.00251	CcSEcCtD
Estramustine—Pancytopenia—Methotrexate—testicular cancer	7.17e-05	0.0025	CcSEcCtD
Estramustine—Mood swings—Doxorubicin—testicular cancer	7.16e-05	0.0025	CcSEcCtD
Estramustine—Thrombocytopenia—Etoposide—testicular cancer	7.02e-05	0.00245	CcSEcCtD
Estramustine—Liver function test abnormal—Doxorubicin—testicular cancer	6.98e-05	0.00244	CcSEcCtD
Estramustine—Dyspnoea—Cisplatin—testicular cancer	6.97e-05	0.00244	CcSEcCtD
Estramustine—Erectile dysfunction—Methotrexate—testicular cancer	6.95e-05	0.00243	CcSEcCtD
Estramustine—Dry skin—Doxorubicin—testicular cancer	6.93e-05	0.00242	CcSEcCtD
Estramustine—Anorexia—Etoposide—testicular cancer	6.83e-05	0.00239	CcSEcCtD
Estramustine—Decreased appetite—Cisplatin—testicular cancer	6.8e-05	0.00237	CcSEcCtD
Estramustine—Diarrhoea—Dactinomycin—testicular cancer	6.77e-05	0.00237	CcSEcCtD
Estramustine—Vomiting—Bleomycin—testicular cancer	6.75e-05	0.00236	CcSEcCtD
Estramustine—Depression—Methotrexate—testicular cancer	6.71e-05	0.00234	CcSEcCtD
Estramustine—Pancytopenia—Epirubicin—testicular cancer	6.71e-05	0.00234	CcSEcCtD
Estramustine—Rash—Bleomycin—testicular cancer	6.69e-05	0.00234	CcSEcCtD
Estramustine—Dermatitis—Bleomycin—testicular cancer	6.69e-05	0.00234	CcSEcCtD
Estramustine—Pruritus—Ifosfamide—testicular cancer	6.42e-05	0.00224	CcSEcCtD
Estramustine—Dyspnoea—Etoposide—testicular cancer	6.39e-05	0.00223	CcSEcCtD
Estramustine—Nausea—Bleomycin—testicular cancer	6.31e-05	0.0022	CcSEcCtD
Estramustine—Vomiting—Dactinomycin—testicular cancer	6.3e-05	0.0022	CcSEcCtD
Estramustine—Rash—Dactinomycin—testicular cancer	6.24e-05	0.00218	CcSEcCtD
Estramustine—Decreased appetite—Etoposide—testicular cancer	6.23e-05	0.00218	CcSEcCtD
Estramustine—Diarrhoea—Ifosfamide—testicular cancer	6.21e-05	0.00217	CcSEcCtD
Estramustine—Pancytopenia—Doxorubicin—testicular cancer	6.21e-05	0.00217	CcSEcCtD
Estramustine—Nausea—Dactinomycin—testicular cancer	5.88e-05	0.00205	CcSEcCtD
Estramustine—Vomiting—Ifosfamide—testicular cancer	5.77e-05	0.00201	CcSEcCtD
Estramustine—Rash—Ifosfamide—testicular cancer	5.72e-05	0.002	CcSEcCtD
Estramustine—Dermatitis—Ifosfamide—testicular cancer	5.72e-05	0.002	CcSEcCtD
Estramustine—Tinnitus—Methotrexate—testicular cancer	5.63e-05	0.00197	CcSEcCtD
Estramustine—Nausea—Ifosfamide—testicular cancer	5.39e-05	0.00188	CcSEcCtD
Estramustine—Diarrhoea—Cisplatin—testicular cancer	5.35e-05	0.00187	CcSEcCtD
Estramustine—Alopecia—Methotrexate—testicular cancer	5.34e-05	0.00186	CcSEcCtD
Estramustine—Tinnitus—Epirubicin—testicular cancer	5.27e-05	0.00184	CcSEcCtD
Estramustine—Flushing—Epirubicin—testicular cancer	5.25e-05	0.00183	CcSEcCtD
Estramustine—Pruritus—Etoposide—testicular cancer	5.07e-05	0.00177	CcSEcCtD
Estramustine—Alopecia—Epirubicin—testicular cancer	5e-05	0.00174	CcSEcCtD
Estramustine—Vomiting—Cisplatin—testicular cancer	4.97e-05	0.00174	CcSEcCtD
Estramustine—Rash—Cisplatin—testicular cancer	4.93e-05	0.00172	CcSEcCtD
Estramustine—Dermatitis—Cisplatin—testicular cancer	4.93e-05	0.00172	CcSEcCtD
Estramustine—Diarrhoea—Etoposide—testicular cancer	4.9e-05	0.00171	CcSEcCtD
Estramustine—Tinnitus—Doxorubicin—testicular cancer	4.88e-05	0.0017	CcSEcCtD
Estramustine—Flushing—Doxorubicin—testicular cancer	4.86e-05	0.0017	CcSEcCtD
Estramustine—Flatulence—Epirubicin—testicular cancer	4.85e-05	0.00169	CcSEcCtD
Estramustine—Muscle spasms—Epirubicin—testicular cancer	4.73e-05	0.00165	CcSEcCtD
Estramustine—Leukopenia—Methotrexate—testicular cancer	4.71e-05	0.00164	CcSEcCtD
Estramustine—Nausea—Cisplatin—testicular cancer	4.65e-05	0.00162	CcSEcCtD
Estramustine—Alopecia—Doxorubicin—testicular cancer	4.62e-05	0.00161	CcSEcCtD
Estramustine—Vomiting—Etoposide—testicular cancer	4.56e-05	0.00159	CcSEcCtD
Estramustine—Rash—Etoposide—testicular cancer	4.52e-05	0.00158	CcSEcCtD
Estramustine—Dermatitis—Etoposide—testicular cancer	4.51e-05	0.00158	CcSEcCtD
Estramustine—Headache—Etoposide—testicular cancer	4.49e-05	0.00157	CcSEcCtD
Estramustine—Flatulence—Doxorubicin—testicular cancer	4.49e-05	0.00157	CcSEcCtD
Estramustine—Chest pain—Methotrexate—testicular cancer	4.48e-05	0.00156	CcSEcCtD
Estramustine—Leukopenia—Epirubicin—testicular cancer	4.41e-05	0.00154	CcSEcCtD
Estramustine—Muscle spasms—Doxorubicin—testicular cancer	4.38e-05	0.00153	CcSEcCtD
Estramustine—Nausea—Etoposide—testicular cancer	4.26e-05	0.00149	CcSEcCtD
Estramustine—Thrombocytopenia—Methotrexate—testicular cancer	4.2e-05	0.00147	CcSEcCtD
Estramustine—Chest pain—Epirubicin—testicular cancer	4.19e-05	0.00146	CcSEcCtD
Estramustine—Anxiety—Epirubicin—testicular cancer	4.18e-05	0.00146	CcSEcCtD
Estramustine—Anorexia—Methotrexate—testicular cancer	4.09e-05	0.00143	CcSEcCtD
Estramustine—Leukopenia—Doxorubicin—testicular cancer	4.08e-05	0.00142	CcSEcCtD
Estramustine—Oedema—Epirubicin—testicular cancer	4.02e-05	0.0014	CcSEcCtD
Estramustine—Thrombocytopenia—Epirubicin—testicular cancer	3.93e-05	0.00137	CcSEcCtD
Estramustine—Insomnia—Methotrexate—testicular cancer	3.88e-05	0.00136	CcSEcCtD
Estramustine—Chest pain—Doxorubicin—testicular cancer	3.88e-05	0.00135	CcSEcCtD
Estramustine—Anxiety—Doxorubicin—testicular cancer	3.86e-05	0.00135	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—STK11—testicular cancer	3.84e-05	0.151	CbGpPWpGaD
Estramustine—Anorexia—Epirubicin—testicular cancer	3.83e-05	0.00134	CcSEcCtD
Estramustine—Dyspnoea—Methotrexate—testicular cancer	3.83e-05	0.00134	CcSEcCtD
Estramustine—Decreased appetite—Methotrexate—testicular cancer	3.73e-05	0.0013	CcSEcCtD
Estramustine—Oedema—Doxorubicin—testicular cancer	3.72e-05	0.0013	CcSEcCtD
Estramustine—Thrombocytopenia—Doxorubicin—testicular cancer	3.64e-05	0.00127	CcSEcCtD
Estramustine—Insomnia—Epirubicin—testicular cancer	3.63e-05	0.00127	CcSEcCtD
Estramustine—Dyspnoea—Epirubicin—testicular cancer	3.58e-05	0.00125	CcSEcCtD
Estramustine—Anorexia—Doxorubicin—testicular cancer	3.54e-05	0.00124	CcSEcCtD
Estramustine—Decreased appetite—Epirubicin—testicular cancer	3.49e-05	0.00122	CcSEcCtD
Estramustine—Insomnia—Doxorubicin—testicular cancer	3.36e-05	0.00117	CcSEcCtD
Estramustine—Dyspnoea—Doxorubicin—testicular cancer	3.31e-05	0.00116	CcSEcCtD
Estramustine—Decreased appetite—Doxorubicin—testicular cancer	3.23e-05	0.00113	CcSEcCtD
Estramustine—Pruritus—Methotrexate—testicular cancer	3.04e-05	0.00106	CcSEcCtD
Estramustine—Diarrhoea—Methotrexate—testicular cancer	2.94e-05	0.00103	CcSEcCtD
Estramustine—Pruritus—Epirubicin—testicular cancer	2.84e-05	0.000993	CcSEcCtD
Estramustine—Diarrhoea—Epirubicin—testicular cancer	2.75e-05	0.00096	CcSEcCtD
Estramustine—Vomiting—Methotrexate—testicular cancer	2.73e-05	0.000953	CcSEcCtD
Estramustine—Rash—Methotrexate—testicular cancer	2.71e-05	0.000945	CcSEcCtD
Estramustine—Dermatitis—Methotrexate—testicular cancer	2.7e-05	0.000944	CcSEcCtD
Estramustine—Headache—Methotrexate—testicular cancer	2.69e-05	0.000939	CcSEcCtD
Estramustine—Pruritus—Doxorubicin—testicular cancer	2.63e-05	0.000918	CcSEcCtD
Estramustine—Vomiting—Epirubicin—testicular cancer	2.55e-05	0.000892	CcSEcCtD
Estramustine—Nausea—Methotrexate—testicular cancer	2.55e-05	0.00089	CcSEcCtD
Estramustine—Diarrhoea—Doxorubicin—testicular cancer	2.54e-05	0.000888	CcSEcCtD
Estramustine—Rash—Epirubicin—testicular cancer	2.53e-05	0.000885	CcSEcCtD
Estramustine—Dermatitis—Epirubicin—testicular cancer	2.53e-05	0.000884	CcSEcCtD
Estramustine—Headache—Epirubicin—testicular cancer	2.52e-05	0.000879	CcSEcCtD
Estramustine—Nausea—Epirubicin—testicular cancer	2.39e-05	0.000833	CcSEcCtD
Estramustine—Vomiting—Doxorubicin—testicular cancer	2.36e-05	0.000825	CcSEcCtD
Estramustine—Rash—Doxorubicin—testicular cancer	2.34e-05	0.000818	CcSEcCtD
Estramustine—Dermatitis—Doxorubicin—testicular cancer	2.34e-05	0.000818	CcSEcCtD
Estramustine—Headache—Doxorubicin—testicular cancer	2.33e-05	0.000813	CcSEcCtD
Estramustine—Nausea—Doxorubicin—testicular cancer	2.21e-05	0.000771	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	9.75e-06	0.0383	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—MMP2—testicular cancer	8.62e-06	0.0339	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—STK11—testicular cancer	7.48e-06	0.0294	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	6.19e-06	0.0243	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	4.5e-06	0.0177	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—MMP2—testicular cancer	4.34e-06	0.0171	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—MMP2—testicular cancer	4.26e-06	0.0168	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—MMP2—testicular cancer	3.25e-06	0.0128	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	3.12e-06	0.0123	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—DNMT3L—testicular cancer	3.09e-06	0.0122	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—STK11—testicular cancer	2.74e-06	0.0108	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KITLG—testicular cancer	2.52e-06	0.0099	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	2.27e-06	0.00891	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	2.25e-06	0.00884	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—FGFR3—testicular cancer	1.87e-06	0.00736	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	1.81e-06	0.0071	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KIT—testicular cancer	1.72e-06	0.00676	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	1.65e-06	0.00649	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—DNMT3L—testicular cancer	1.56e-06	0.00613	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	1.2e-06	0.00472	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—INSL3—testicular cancer	1.11e-06	0.00436	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	1.11e-06	0.00435	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—H2AFZ—testicular cancer	1.08e-06	0.00425	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—H2AFZ—testicular cancer	5.45e-07	0.00214	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—H2AFZ—testicular cancer	3.55e-07	0.00139	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STK11—testicular cancer	3.53e-07	0.00139	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KITLG—testicular cancer	3.26e-07	0.00128	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HPGDS—testicular cancer	3.07e-07	0.00121	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR3—testicular cancer	2.42e-07	0.000953	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—STK11—testicular cancer	2.23e-07	0.000877	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KIT—testicular cancer	2.23e-07	0.000875	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HPGDS—testicular cancer	1.89e-07	0.000744	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—STK11—testicular cancer	1.37e-07	0.00054	CbGpPWpGaD
